We all know someone who has had a heart attack or other cardiac condition. And despite significant therapeutic and diagnostics advancements, heart disease and cardiac events remain the leading causes of death in both men and women in the United States and cost more than $200 billion in health care services annually.
Earlier and more accurate arrhythmia diagnosis can help change that, but we need your help!
Current ECG technology used to identify cardiac rhythm abnormalities can lead to lost opportunities to provide a diagnoses, increased expense, and patient frustration. In an industry that is constantly challenging providers to be become faster, better, and cheaper. This doesn’t add up.
VivaQuant technology and monitoring service steps up to the challenge by enabling faster diagnosis, a better patient experience, and a more efficient business model that puts the clinician in control.